Our partner, a biopharmaceutical company based in the Nordics, were looking to expand into the US market and approached us to assist with their first MSL hires there. Read the full case study to learn on how we assisted them in finding suitable candidates: https://lnkd.in/egvgUTaP #GlobalGrowthPartners #LifeSciences #Biotech #Expansion
Proclinical Staffing’s Post
More Relevant Posts
-
Despite biopharmaceutical companies improving their ability to predict price outcomes due to technological advancements, the Inflation Reduction Act (IRA) poses a new challenge. The IRA has introduced an unpredicted level of uncertainty that the biopharma industry has not experienced before. Jeffrey B. Kindler, Former Chairman and CEO at Pfizer and Executive Chairman at EntityRisk, says that the IRA was developed with no guidance from biopharma companies, and it remains unclear how the government will determine drug prices or which drugs will be affected. Although biopharmaceutical companies cannot change the outcomes of the IRA, they will need to evolve their businesses to be ready to adapt to fast changes. Listen to the full conversation between Jeff Kindler, Dana Goldman, and Neal Masia here to learn more: https://lnkd.in/dKN8ur8h #drugpricing #IRA #InflationReductionAct
To view or add a comment, sign in
-
LAST CHANCE to submit your topics and presentations for the 2024 ASAP BioPharma Conference! The conference will be held in Boston from November 4-6, 2024. We need your expertise and thought-leadership to ensure the most valuable and current topics regarding partnering, collaboration, and alliance management in the biopharma and life sciences industries are addressed. Don't miss this opportunity to contribute your knowledge! Submit your topics before the deadline on Friday, May 3, 2024 at https://lnkd.in/ehXhGm7U. #alliancemanagement #alliances #strategicalliances #alliancemanagers #collaboration #strategicpartnerships #pharmaceutical #pharmaceuticalindustry #biopharma #biotech #biotechnology #biotechindustry
To view or add a comment, sign in
-
Forming successful alliances in the biopharmaceutical industry is a strategic imperative, yet navigating the intricate process of partner identification, evaluation, and management can be a formidable challenge. Read this insightful article outlining key considerations for such an alliance and how Seleksus Consulting® can aid in maximizing the value from such strategic partnerships. https://shorturl.at/qrRV9 #partnerships #collaboration #mergersandacquisitions #marketaccess #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare #lifesciences #lifesciencesconsulting
To view or add a comment, sign in
-
America has led the global #biopharmaceutical industry in recent decades on measures ranging from the number of new drugs it produces to its share of the world’s value-added production. This success has been due to its large domestic market and an intentional series of policy choices that have spurred biopharmaceutical innovation, including robust #IP protections, limits on government drug price setting, and supportive #science policies and innovation clusters. But the United States is now second-guessing its successful policy choices and risks neglecting its leadership position in the industry while #China is actively aspiring to gain a competitive advantage, according to our latest report. https://lnkd.in/edxnHwNV
Not Again: Why the United States Can’t Afford to Lose Its Biopharma Industry
itif.org
To view or add a comment, sign in
-
Several successful biopharmaceutical companies have already realised the advantages of conducting operations here in Australia. Have you explored these benefits yet. Get in touch with Southern RNA to be your preferred mRNA Manufacturing partner! Contact us to discover: - 𝗛𝗼𝘄 𝗥&𝗗 𝗰𝗮𝗻 𝗯𝗲 𝗺𝗼𝗿𝗲 𝗰𝗼𝘀𝘁-𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮, 𝘄𝗶𝘁𝗵 𝘁𝗮𝘅 𝗶𝗻𝗰𝗲𝗻𝘁𝗶𝘃𝗲𝘀 𝘂𝗽 𝘁𝗼 𝟰𝟴.𝟱%. - 𝗛𝗼𝘄 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝗣𝗵𝗮𝘀𝗲 𝗜 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 𝗶𝗻 𝗮𝘀 𝗹𝗶𝘁𝘁𝗹𝗲 𝗮𝘀 𝗳𝗼𝘂𝗿 𝘄𝗲𝗲𝗸𝘀. - 𝗦𝗼𝘂𝘁𝗵𝗲𝗿𝗻 𝗥𝗡𝗔'𝘀 𝗽𝗹𝗮𝗻𝘀 𝘁𝗼 𝗰𝗼𝗺𝗺𝗲𝗻𝗰𝗲 𝗚𝗠𝗣 𝗺𝗥𝗡𝗔 𝗱𝗿𝘂𝗴 𝘀𝘂𝗯𝘀𝘁𝗮𝗻𝗰𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝘀 𝗲𝗮𝗿𝗹𝘆 𝗮𝘀 𝗤𝟭 𝟮𝟬𝟮𝟱. 𝗜𝗻𝗳𝗼@𝘀𝗼𝘂𝘁𝗵𝗲𝗿𝗻𝗥𝗡𝗔.𝗰𝗼𝗺.𝗮𝘂
To view or add a comment, sign in
-
We are pleased to announce the release of our new article on key considerations for strategic alliances in biopharmaceutical industry. #partnerships #collaboration #mergersandacquisitions #marketaccess #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare #lifesciences #lifesciencesconsulting
Forming successful alliances in the biopharmaceutical industry is a strategic imperative, yet navigating the intricate process of partner identification, evaluation, and management can be a formidable challenge. Read this insightful article outlining key considerations for such an alliance and how Seleksus Consulting® can aid in maximizing the value from such strategic partnerships. https://shorturl.at/qrRV9 #partnerships #collaboration #mergersandacquisitions #marketaccess #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare #lifesciences #lifesciencesconsulting
Strategic alliances in biopharmaceutical industry
seleksusconsulting.com
To view or add a comment, sign in
-
Don’t miss the Horizons: Life Sciences 2024 report! This is the fifth installment of this series that features data collected from 500 industry professionals. Download it today so you stay ahead in this rapidly evolving life sciences industry: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
The Horizons: Life Sciences 2024 report is here! In our fifth installment of this series, we focus on the biopharmaceutical manufacturing facility – how companies manage their capital budgets and operational spending, and what are the key trends in facility, equipment and process. Built on data from 500 industry professionals, plus insights from our most knowledgeable experts, this report is a must-read for anyone who wants to stay ahead in the rapidly evolving life sciences sector. Download it for free today: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
To view or add a comment, sign in
-
A great (free!!) resource for all. Extending this invite to you all so you can download your free copy!!
The Horizons: Life Sciences 2024 report is here! In our fifth installment of this series, we focus on the biopharmaceutical manufacturing facility – how companies manage their capital budgets and operational spending, and what are the key trends in facility, equipment and process. Built on data from 500 industry professionals, plus insights from our most knowledgeable experts, this report is a must-read for anyone who wants to stay ahead in the rapidly evolving life sciences sector. Download it for free today: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
To view or add a comment, sign in
-
⚠ATTENTION⚠ The new HORIZONS REPORT BY CRB is OUT NOW! Gather insights on the latest news and trends of the Life Science Industry 🔥 that our industry experts such as Estapé David & Basilio Caneva compiled in a well-designed and informative booklet 📖. EXPLORE THE HORIZONS REPORT - DOWNLOAD HERE ➡https://hubs.la/Q02MgJD00 ⬅ #LifeScience #Horizonsreport #CRB #dontmissthis
The Horizons: Life Sciences 2024 report is here! In our fifth installment of this series, we focus on the biopharmaceutical manufacturing facility – how companies manage their capital budgets and operational spending, and what are the key trends in facility, equipment and process. Built on data from 500 industry professionals, plus insights from our most knowledgeable experts, this report is a must-read for anyone who wants to stay ahead in the rapidly evolving life sciences sector. Download it for free today: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
To view or add a comment, sign in
-
Don’t miss the Horizons: Life Sciences 2024 report! This is the fifth installment of this series that features data collected from 500 industry professionals. Download it today so you stay ahead in this rapidly evolving life sciences industry: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
The Horizons: Life Sciences 2024 report is here! In our fifth installment of this series, we focus on the biopharmaceutical manufacturing facility – how companies manage their capital budgets and operational spending, and what are the key trends in facility, equipment and process. Built on data from 500 industry professionals, plus insights from our most knowledgeable experts, this report is a must-read for anyone who wants to stay ahead in the rapidly evolving life sciences sector. Download it for free today: https://hubs.la/Q02MgJD00 #LifeSciences #Biopharma #PharmaceuticalManufacturing #CRBHorizons
To view or add a comment, sign in
232,809 followers